NZ Hepatitis Research Review Issue 43

In this issue:

  -  Pan-PPAR agonist lanifibranor in NASH
  -  Bariatric surgery for non-alcoholic steatohepatitis
  -  Entecavir vs tenofovir for HCC prevention
  -  Long-term follow-up of IFN-α for HBeAg-positive chronic HBV
  -  HCV-related liver transplantation in Australia and New Zealand
  -  GP education programme for diagnosis and treatment of chronic HCV
  -  Liver inflammation in Asian patients with chronic HBV with normal ALT
  -  HCV eradication improves cognitive function
  -  Effectiveness of broad access direct-acting antivirals for hepatitis
  -  Outcomes in adults with NAFLD

Please login below to download this issue (PDF)